Abstract: The present invention relates to a pharmaceutical composition comprising (a) 7?-hydroxycholesterol, (b) a water soluble organic solvent, preferably propylene glycol and/or DMSO, and (c) a solubilizing agent, preferably PEG hydrated castor oil, and to a method for preparing the same. This composition is suitable for preparing an intravenously administered preparation and comprises the pharmaceutically active substance ?-hydroxycholesterol, which is poorly soluble in water.
Type:
Grant
Filed:
January 12, 2017
Date of Patent:
January 15, 2019
Assignee:
IMMUNOPHARM AG
Inventors:
Werner Bieberschulte, Christine Grimm, Rohan Charles Fernando